Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States

PURPOSE: The aim of this study was to assess the cost effectiveness of letermovir prophylaxis with the option for subsequent pre-emptive therapy (PET) for the prevention of cytomegalovirus (CMV) infection compared with a PET-only scenario in adult allogeneic hematopoietic stem cell transplant (allo-...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepassi, Aryana, Saunders, Ila M., Bounthavong, Mark, Taplitz, Randy A., Logan, Cathy, Watanabe, Jonathan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169956/
https://www.ncbi.nlm.nih.gov/pubmed/36840894
http://dx.doi.org/10.1007/s41669-023-00398-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169956/
https://www.ncbi.nlm.nih.gov/pubmed/36840894
http://dx.doi.org/10.1007/s41669-023-00398-y

Ejemplares similares